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ABSTRACT 
Wegener’s Granulomatosis is characterized by granulomas of the upper and lower respiratory tracts, glomerulonephritis and 
systemic vasculitis of small and medium sized vessels. A “limited” form of the disease points to the presence of clinical 
findings restricted to the upper respiratory tract and/or lungs. Limited sino-nasal disease is rare and, coupled with the higher 
incidence of tuberculosis, bacterial and fungal sinusitis, a timely diagnosis often poses a challenge. We present a case of a 
female patient in the seventh decade with features of pansinusitis and nasal polyps, initially diagnosed as, granulomatous lesion 
of infective etiology, which later turned out to be Wegener’s granulomatosis. 
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egener’s granulomatosis (WG) is an 
uncommon primary systemic vasculitis 
characterized by the triad of acute necrotizing 
granulomas of the upper respiratory tract and/or the lower 
respiratory tract, necrotizing or granulomatous vasculitis 
involving small to medium sized vessels and necrotizing 
glomerulonephritis [1]. The involvement of nose and 
paranasal sinuses may initially be in the form of chronic 
non specific inflammation [2] and the radiological features 
often mimic other entities most notably nasal cocaine 
necrosis, sarcoidosis, and extranodal nasal lymphoma [3]; 
however, presentation with nasal polyposis is uncommon.  
CASE REPORT 
A 61 year old female patient presented to the OPD with 
history of persistent mucoid nasal discharge, headache, 
pain around nose and middle part of face, low grade fever 
on and off since 4 months and one or two episodes of self-
limited epistaxis. The CT scan of paranasal sinuses 
showed pansinusistis with nasal polyp [Figure1].  
 She had undergone polypectomy at another medical 
facility where the diagnosis of granulomatous lesion, 
possibly of mycobacterial or fungal aetiology, was made 
and treatment started. However, since 1 month the 
discharge had turned purulent along with redness and pain 
in the eyes and associated with high grade fever, loss of 
appetite and weight and malaise.  
 Clinical examination revealed saddle nose deformity 
[Figure2], tenderness over both maxillary sinuses, crusting 
of nasal mucosa with polypoidal thickening, septal 
perforation and foul smelling discharge.  
W 
Giri et al                          Wegener’s granulomatosis masquerading as Pansinusitis and Nasal Polyposis 
Vol 3 Issue 2 Apr – Jun 2017                                                        Indian J Case Reports / 71 
       
Figures: Fig. 1 - NCCT of nose and paranasal sinuses showing polypoid protrusion of the maxillary mucosa into right nasal 
cavity. Fig. 2 - Saddle nose deformity. Fig. 3 - Chest X-ray showing a solitary nodular opacity in the upper lobe of the left lung 
(arrow). 
      
Figure 4 - Photomicrograph showing widespread necrosis with perivascular inflammatory infiltrate and fibrinoid necrosis of 
the vessel wall (H&E, 400X). Figure 5 - Photomicrograph showing leukocytoclastic vasculitis and fibrinoid necrosis of the 
vessel walls and a Langhans giant cell (arrow) (H&E, 400X) 
 Laboratory tests showed anemia (Hb = 8.5 gm/dL) and 
elevated TLC (12,450/μL). Kidney function tests (Sr. 
creatinine = 0.8mg/dL and BUN = 18 mg/dL), liver 
function tests and ESR (12 mm in 1st hour) were within 
normal limits. Her chest X-ray showed a solitary nodule in 
the left mid-zone [Figure 3]. A repeat nasal mucosal 
biopsy showed the presence of geographic, dirty necrosis 
with Langhans giant cells and vasculitis with fibrinoid 
necrosis of the blood vessels [Figures 4 and 5]. Fite-Faraco 
and per-iodic acid schiff (PAS) stains were non-
contributory. Cytoplasmic, anti-neutrophil cytoplasmic 
antibody (c-ANCA) by indirect immunofluorescence (IIF) 
was weakly positive (1:40 titers).  
Thus a diagnosis of WG was made and the patient was 
put on methotrexate (15mg/week) and prednisolone 
(40mg/day) over 4 weeks. There was an improvement in 
her symptoms and she was discharged after 4 weeks with 
tapering dose of prednisolone while maintaining 
methotrexate. However, the patient was lost to follow up 
and presented in the emergency with hemoptysis a month 
later. Her kidney function tests were deranged and she died 
the next morning due to diffuse alveolar haemorrhage. 
DISCUSSION 
The American College of Rheumatology (ACR), in 1990, 
outlined 4 criteria [4] to define WG out of which at least 2 
should be present, namely, 1) painful or painless nasal and 
oral ulcers or purulent or bloody nasal discharge; 2) chest 
radiograph showing the presence of nodules, fixed 
infiltrates or cavities; 3) microhaematuria (more than five 
red blood cells per high power field) or red cell casts in 
urine sediment, and 4) histological changes showing 
granulomatous inflammation within the wall of an artery 
or in the perivascular or extravascular area (artery or 
arteriole). 
Wegener’s Granulomatosis Etanercept Trial (WGET) 
[5,6] group defined limited disease as one which fulfilled 
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the ACR criteria along with the following features: 1) The 
patient has no red blood cell casts in the urine. 2) If 
hematuria is present (but no red blood cell casts), the 
serum creatinine is ≤1.4 mg/dl, no evidence of a rise in 
creatinine >25% above the patient’s baseline level. 3) 
Circumscribed pulmonary involvement, such that the room 
air PO2 is >70 mm Hg or the room air O2 saturation by 
pulse oximetry is >92%. Pulmonary hemorrhage may be 
treated as limited disease provided there is no evidence of 
progression of the process. 4) No disease may exist within 
any other critical organ that, without the immediate 
institution of maximal therapy (i.e., pulse 
methylprednisolone and daily oral cyclophosphamide), 
threatens the function of that organ and/or the patient’s 
life. 
The exact incidence and prevalence of Wegener’s 
granulomatosis in India is not known [7]. Of the 25 cases 
analyzed by Kumar A et al [8], only 2 had limited disease 
involving the upper respiratory tract. Pradhan VD et al [9] 
reported limited disease in 7 out of the 28 patients studied, 
out of which 6 had upper respiratory tract involvement; of 
these cases, 71.4% showed ANCA positivity as compared 
to 81.2% cases of classical WG. The WGET cohort of 180 
patients included 52 patients with limited disease, 88.5% 
of whom had ENT involvement [6]. However, none of 
these studies have documented nasal polyps as a 
presenting feature of the disease. The commonest 
symptoms of active sinonasal disease elucidated are nasal 
crusting (69%), chronic rhinosinusitis (CRS) symptoms 
(61%), nasal obstruction (58%), and serosanguinous nasal 
discharge (52%) [10]. Although few authors have reported 
the presence of sinonasal mass or tumour tissue at initial 
presentation of WG [11-14], only 1 case report of WG that 
demonstrated nasal polyp  as one of the presenting features 
has been documented [15]. The imaging features of 
granulomatous involvement of the sinonasal compartment 
include osseous erosion and destruction, mucosal 
thickening and neoosteogenesis, which overlap with the 
aforementioned entities [3]. 
Histopathologically, WG lesions are characterized by 
granulomatous inflammation (scattered giant cells, poorly-
formed granulomas), necrosis (neutrophilic 
microabscesses, geographic necrosis) and angiitis 
(leukocytoclastic, necrotizing, granulomatous). The 
presence of any one or two of these traits should alert the 
pathologist to the possibility of WG [16]. However, these 
features are shared by infectious diseases (e.g. 
tuberculosis, leprosy, fungal infection etc.), lymphoma and 
autoimmune disorders like sarcoidosis [17]. C-ANCA 
measurement by IIF is a sensitive marker; however it is 
difficult to establish a diagnosis of WG in the early stages 
or in the limited forms where the sensitivity of the test may 
fall to 67% [18]. 
The present case is unique because the initial 
symptoms were non-specific and imaging showed  a rare 
presenting feature of WG, an uncommon disease; this was 
compounded by the  histological attributes overlapping 
with those of infectious diseases (especially tuberculosis), 
which have a higher prevalence in this region. 
CONCLUSION 
The increased recognition of WG in India mandates that 
isolated, unresolving or worsening sinonasal lesions, 
including polyps, despite adequate treatment of the 
presumed diagnosis and in the absence of an objective 
evidence of chronic infection or malignancy, should raise 
the suspicion of limited WG. The presence of one or two 
of the above mentioned histological features should raise 
the suspicion of WG. The diagnosis should be arrived at 
by correlating clinical, radiological and histological 
features and corroborated with ANCA titers. 
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